# Efficacy and Safety of the CorVad Percutaneous Ventricular Assist System in Cardiogenic Shock

> **NCT06646224** · NA · RECRUITING · sponsor: **Shenzhen Core Medical Technology CO.,LTD.** · enrollment: 50 (estimated)

## Conditions studied

- Cardiogenic Shock

## Interventions

- **DEVICE:** CorVad Percutaneous Ventricular Assist System

## Key facts

- **NCT ID:** NCT06646224
- **Lead sponsor:** Shenzhen Core Medical Technology CO.,LTD.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-10-12
- **Primary completion:** 2025-05-31
- **Final completion:** 2025-05-31
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2024-10-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06646224

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06646224, "Efficacy and Safety of the CorVad Percutaneous Ventricular Assist System in Cardiogenic Shock". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT06646224. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*